Usage: Buprenorphine Sublingual Tablets are indicated for treating opioid dependence, primarily during the induction phase, and should be used alongside a comprehensive treatment plan that includes counseling and psychosocial support.
buprenorphine - buprenorphine patch
(Buprenorphine)
Rhodes Pharmaceuticals L.P.
buprenorphine and naloxone
(Buprenorphine and Naloxone)
Rhodes Pharmaceuticals L.P.
Usage: Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence, and should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.
(Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate)
Rhodes Pharmaceuticals L.P.
dilaudid
(hydromorphone hydrochloride)
Rhodes Pharmaceuticals L.P.
Usage: DILAUDID Oral Solution and Tablets are indicated for managing severe pain requiring opioid analgesics when alternative treatments are inadequate. Use is limited due to risks of addiction and misuse, and they should only be prescribed when non-opioid options are ineffective or intolerable. Extended use is discouraged.